NPI: 1104013879 · IRVINE, CA 92604 · Professional Counselor · NPI assigned 09/26/2007
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 09/26/2007 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,824 | $67K |
| 2019 | 1,564 | $70K |
| 2020 | 40,136 | $566K |
| 2021 | 106,393 | $1.77M |
| 2022 | 87,330 | $1.32M |
| 2023 | 14,091 | $188K |
| 2024 | 529 | $27K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 144,168 | 132,757 | $1.86M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 64,173 | 60,822 | $1.08M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 17,694 | 16,744 | $447K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4,655 | 4,515 | $167K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,403 | 2,074 | $129K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,071 | 1,924 | $105K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,217 | 2,965 | $86K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,557 | 932 | $85K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 674 | 601 | $22K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,359 | 1,309 | $9K |
| 99201 | 126 | 125 | $4K | |
| 90715 | 31 | 30 | $1K | |
| 90674 | 214 | 213 | $1K | |
| 90686 | 67 | 67 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 111 | 109 | $852.44 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 46 | 46 | $760.24 |
| 86580 | 130 | 126 | $371.89 | |
| 0064A | 18 | 17 | $160.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 180 | 89 | $123.54 |
| 3074F | 1,747 | 1,660 | $112.58 | |
| 1036F | 1,713 | 1,598 | $95.53 | |
| 3078F | 1,366 | 1,306 | $34.30 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 71 | 70 | $27.96 |
| 3008F | 941 | 891 | $18.10 | |
| 81002 | 25 | 24 | $6.45 | |
| 3079F | 597 | 581 | $0.00 | |
| 3075F | 219 | 215 | $0.00 | |
| 1159F | 1,128 | 1,069 | $0.00 | |
| 1160F | 1,153 | 1,078 | $0.00 | |
| 3077F | 13 | 13 | $0.00 |